<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01567397</url>
  </required_header>
  <id_info>
    <org_study_id>ReDuCTO ID 7090</org_study_id>
    <nct_id>NCT01567397</nct_id>
  </id_info>
  <brief_title>Registry of Dupuytren's Contracture Treatment Outcomes</brief_title>
  <acronym>ReDuCTO</acronym>
  <official_title>Registry of Dupuytren's Contracture Treatment Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität Dresden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GWT-TUD GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Technische Universität Dresden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Experience with Microbial Collagenase (trade name Xiapex) in Europe currently is limited to
      randomised controlled studies.While such studies are essential to determine efficacy and
      safety of the product (usually compared to placebo), they provide no information on the
      effectiveness of the drug and further aspects of its use (feasibility, tolerability, quality
      of life and other patient-related outcomes) in the typical &quot;real-life&quot; setting under clinical
      practice conditions.Thus, the present study aims to collect data on the

        -  Drug utilization of Microbial Collagenase in the hand of physicians, with focus on
           feasibility, treatment patterns, and effectiveness in clinical practice

        -  Context of Microbial Collagenase therapy (setting, patient characteristics, concomitant
           treatment, follow-up therapy)

        -  Effectiveness (with focus on functionality)

        -  Tolerability

        -  Patient-related outcomes: patient satisfaction, health-related quality of life

        -  Physician satisfaction with therapy

        -  Resource utilization (hospital stays, drug consumption, concomitant medication etc.)

        -  Long-term outcomes
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">87</enrollment>
  <condition>Dupuytren's Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Dupuytren's Disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  palpable cord due to Dupuytren's Disease (pretreated or untreated)

          -  satisfactory knowledge of German to be able to fill out questionnaires

          -  written informed consent

        Exclusion Criteria:

          -  contraindication to Microbial Collagenase (according to Prescription Information)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Pittrow, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Institute for Clinical Pharmacology, Medical Faculty, Technical University Dresden, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wilhelm Kirch, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Clinical Pharmacology (Director), Medical Faculty, Technical University, Dresden, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Max Härle, MD</last_name>
    <role>Study Director</role>
    <affiliation>Orthopädische Klinik, Markgröningen, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jörg Witthaut, MD</last_name>
    <role>Study Director</role>
    <affiliation>Schön Klinik Vogtareuth</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Riccardo Giunta, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hand Surgery, Ludwig-Maximilian-University Munich, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Prof. Dr. Max Haerle</name>
      <address>
        <city>Markgröningen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prof. Dr. Riccardo Giunta</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Several undisclosed sites</name>
      <address>
        <city>Various cities</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Joerg Witthaut</name>
      <address>
        <city>Vogtareuth</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.egms.de/static/de/journals/gpras/2015-5/gpras000034.shtml</url>
    <description>Publication of results in the German Mecial Science (GMS) database</description>
  </link>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2012</study_first_submitted>
  <study_first_submitted_qc>March 29, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2012</study_first_posted>
  <last_update_submitted>December 20, 2016</last_update_submitted>
  <last_update_submitted_qc>December 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contracture</mesh_term>
    <mesh_term>Dupuytren Contracture</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

